Prostate Cancer - Results from #19660

Adenocarcinoma of the prostate with Gleason pattern 5 on core biopsy: Frequency of diagnosis, morphologic subpatterns, and relation to pattern distribution based on the modified Gleason grading system - Abstract November 5, 2014

Update on prostate cancer in black men within the UK - Abstract November 5, 2014

Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year study - Abstract November 5, 2014

Effect of rectal enema on intrafraction prostate movement during image-guided radiotherapy - Abstract November 5, 2014

Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: Results of a phase II nonrandomized expansion study - Abstract November 4, 2014

The relationship between total testosterone levels and prostate cancer: A review of the continuing controversy - Abstract November 4, 2014

Associations between patient-provider communication and socio-cultural factors in prostate cancer patients: A cross-sectional evaluation of racial differences - Abstract November 4, 2014

Relationship between male pattern baldness and the risk of aggressive prostate cancer: An analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial - Abstract November 4, 2014

The oncological outcome and validation of Japan Cancer of the Prostate Risk Assessment score among men treated with primary androgen-deprivation therapy - Abstract November 4, 2014

Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies - Abstract November 4, 2014

Physical functioning for prostate health - Abstract November 3, 2014

Docetaxel with or without zoledronic acid for castration-resistant prostate cancer - Abstract November 3, 2014

ASCO endorses AUA/ASTRO guideline on adjuvant and salvage radiotherapy after prostatectomy November 3, 2014

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer - Abstract November 1, 2014

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase 3 metastatic castration resistant prostate cancer trial - Abstract November 1, 2014

Poor glycemic control is associated with reduced prostate-specific antigen concentrations in men with type 1 diabetes - Abstract November 1, 2014

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan - Abstract November 1, 2014

Transperineal in-bore 3-T MR imaging-guided prostate biopsy: A prospective clinical observational study - Abstract November 1, 2014

Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: A SEER-based study - Abstract October 31, 2014

Achievements and perspectives in prostate cancer phase 3 trials from genitourinary research groups in Europe: Introducing the Prostate Cancer Consortium in Europe - Abstract October 31, 2014

Page 984 of 1447